Ir al contenido

Actualización del estudio de fase II GENERATION HD2

Roche has announced the continuation of the GENERATION HD2 Phase II clinical trial evaluating tominersen in individuals with early signs of Huntington’s disease. Following an interim analysis by an independent committee, no […]

Conferencia EHA 2025

Nos complace anunciar que la Asociación Europea de Huntington organizará su 5ª Conferencia Bianual en Bucarest, Rumanía, del 25 al 28 de septiembre de 2025. "El lema "Juntos daremos forma a nuestro futuro, ¡nosotros somos el cambio!

Una mirada retrospectiva al Congreso HDYO 2025

The HDYO Congress 2025 brought together young people, families, researchers, and professionals from around the world for an unforgettable event dedicated to the Huntington’s Disease community. Over three inspiring days, […]

es_ESSpanish